ADIPOQ and endometrial cancer: A strong correlation between the expression levels of adiponectin and IL6 was noted (Figure S1), that suggest that these markers may have similar regulatory mechanisms and work via interconnected pathways such as MAPK, PI3K/Akt/mTOR and MEK/ERK, indicating their joint involvement in endometrial cancer development.